Consent to Telemedicine and Informed Consent for Medications

Last revised: February 19, 2025

Please read this document thoroughly, including the Consent to Compounded Semaglutide and Compounded Tirzepatide, which outlines important risks and benefits of these medications.

Consent to Telemedicine

By using the Lovely Meds platform, your telemedicine visits will be provided by Beluga Health, P.A. (“Beluga”). By engaging in telemedicine consultations with a licensed Beluga healthcare practitioner in your state, you agree to the following terms. All visits are asynchronous unless real-time synchronous telemedicine is required by state law.

By clicking the checkbox agreeing to these terms during your Lovely Meds account creation, you agree to the Beluga Asynchronous Telemedicine Informed Consent and acknowledge the following:

I HAVE READ AND UNDERSTAND THE TERMS PRESENTED OR LINKED HEREIN AND GIVE MY INFORMED CONSENT TO PARTICIPATE IN ASYNCHRONOUS TELEMEDICINE (OR REAL-TIME SYNCHRONOUS TELEMEDICINE IF REQUIRED BY STATE LAW).

Informed Consent to Compounded Semaglutide and Compounded Tirzepatide & Safety Information

During your telemedicine visit, a licensed provider will evaluate your medical history, medications, and other relevant information to determine if Compounded Semaglutide or Compounded Tirzepatide is appropriate for you.

Our Safety Information page, located [here], provides important safety details about both compounded and name-brand medications that may be prescribed through the Lovely Meds platform, including their potential benefits and risks.

It is your responsibility to review and discuss all safety information with a qualified healthcare professional before consenting to treatment with these or any other medications.

By clicking the checkbox agreeing to these terms during your Lovely Meds account creation, you acknowledge and agree to the following:

You have read and understand the potential side effects and risks.
You will remain under the care of your primary medical provider for all other conditions.
No guarantees of weight loss results.
Compounded medications are not FDA-approved.
No refunds.
You will truthfully disclose all requested health information.
You will follow dosage and administration instructions and not share needles.

Certification of Consent to Proceed with Treatment

By clicking the checkbox agreeing to these terms during your Lovely Meds account creation, you confirm that you understand and agree to the information provided, accept all risks associated with Compounded Semaglutide and/or Compounded Tirzepatide, and consent to proceed with treatment.

Call/Email/Text Messaging Consent

You explicitly consent to Lovely Meds, its healthcare practitioners, and medical partners contacting you via calls, emails, or text messages (both SMS and MMS) regarding Personal Information and Sensitive Information (as defined in the Lovely Meds Privacy Policy), appointments, or other matters related to your telemedicine services.

These communications may be made using an auto-dialer or pre-recorded/artificial voice, even if your number is listed on a do-not-call registry. Standard rates from your phone carrier may apply. You may withdraw this consent at any time by emailing hello@lovelymeds.com.

This Telemedicine Informed Consent remains valid throughout your treatment with Lovely Meds.

Changes to This Notice

We reserve the right to modify this Notice and will post the updated version on our website.